The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Balasooriya ER, Wu Q, Ellis H, Zhen Y, et al. Clin Cancer Res 2024;30:2181-2192.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Balasooriya ER, Wu Q, Ellis H, Zhen Y, et al. The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations. Clin Cancer Res 2024;30:2181-2192.
PMID: 38437671